I am thrilled about a new detection test for Ovarian cancer that has been developed by researchers at the Yale School of Medicine. The test uses a platform to detect 6 protein biomarkers instead of 4. The accuracy of detection is 99.4 percent accurate. Gol Mor , M.D. is the chief investigator. The Early detection Research Network of NCI evaluated the result of the Stage II clinical trial. Stage III trials have begun.